V Square Quantitative Management LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

V Square Quantitative Management LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 134.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,625 shares of the healthcare conglomerate’s stock after purchasing an additional 3,801 shares during the quarter. UnitedHealth Group accounts for 0.5% of V Square Quantitative Management LLC’s portfolio, making the stock its 26th largest position. V Square Quantitative Management LLC’s holdings in UnitedHealth Group were worth $3,277,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in UNH. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock worth $44,150,045,000 after purchasing an additional 250,291 shares during the period. Wellington Management Group LLP boosted its stake in shares of UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. Capital Research Global Investors increased its stake in shares of UnitedHealth Group by 2.2% in the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after purchasing an additional 324,733 shares in the last quarter. Capital International Investors lifted its position in UnitedHealth Group by 4.8% during the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after purchasing an additional 542,424 shares in the last quarter. Finally, Norges Bank purchased a new stake in UnitedHealth Group in the fourth quarter worth about $5,802,231,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. TD Cowen dropped their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Barclays boosted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Finally, Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

Read Our Latest Research Report on UnitedHealth Group

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Up 1.2 %

NYSE:UNH traded up $6.32 during midday trading on Tuesday, hitting $523.55. 2,310,998 shares of the company traded hands, compared to its average volume of 4,216,200. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm’s fifty day moving average is $487.65 and its 200-day moving average is $510.99. The firm has a market capitalization of $481.87 billion, a P/E ratio of 32.00, a P/E/G ratio of 1.52 and a beta of 0.55. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the prior year, the firm posted $6.26 EPS. The firm’s revenue was up 8.6% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.